The Peer-Reviewed Forum for Evidence in Benefit Design ™ May/June 2013
Volume 6, Number 4
For Payers, Purchasers, Policymakers, and Other Healthcare Stakeholders
EDITORIAL
Reflections on Japan’s Complex Medical Culture David B. Nash, MD, MBA BUSINESS
Optimizing the Economic Impact of rtPA Use in a Stroke Belt State: The Case of South Carolina ™
Abby Swanson Kazley, PhD; Kit N. Simpson, DrPH; Annie Simpson, PhD; Edward Jauch, MD; Robert J. Adams, MD Stakeholder Perspective by Albert Tzeel, MD, MHSA, FACPE REGULATORY
US Propofol Drug Shortages: Review of the Problem and Stakeholder Analysis Christopher Hvisdas, PharmD Candidate; Andrea Lordan, PharmD Candidate; Laura T. Pizzi, PharmD, MPH; Brandi N. Thoma, PharmD Stakeholder Perspective by Jack E. Fincham, PhD, RPh CLINICAL
Opioid Utilization Patterns among Medicare Patients with Diabetic Peripheral Neuropathy Jacqueline Pesa, MSEd, PhD, MPH; Roxanne Meyer, PharmD; Tiffany P. Quock, PhD, MS; Stacy K. Rattana, RN, BSN; Samir H. Mody, PharmD, MBA Stakeholder Perspective by Curtis Wander, PharmD
Industry Trends The Race to Open Enrollment: Critical Success Factors for Exchanges AMCP Highlights
6
EST. 2008
YEAR ANNIVERSARY
Payer’s Trends An Inside Look at Managed Care Executive Conversations within the Health Payer Council: What Is Evidence?
www.AHDBonline.com ©2013 Engage Healthcare Communications, LLC